News About: Pharm. Industry
Medytox achieved highest ever since foundation, KRW 28.8 billion sales, on 1st quarter
Medytox recorded the largest performance ever since its foundation on the first quarter of the year.
A biopharmaceutical company, Medytox(CEO Hyun-ho Jung), made an official notice of its tentative performance on th...
Active contacts for M&As between pharmaceutical and biopharmaceutical companies
It was observed mergers and acquisitions between medium and small pharmaceutical companies and biopharmaceutical companies have actively been made.
According to the pharmaceutical industry, large pharmaceutical compa...
Pharmaceutical companies to expand businesses into interesting fields
Listed pharmaceutical companies have started to expand their business into various fields, such as the communal dining service, insurance service, stone, and sporting goods fields.
According to the Yakup Shinmoon’s(w...
Noticeable uptrend of pharmaceutical exports
Uptrends on pharmaceutical exports have been very noticeable. The active global market expansion of pharmaceutical companies has been reflected in numbers. Particularly, the Hanmi Pharm’s technology export has raised ...
Unlisted pharmaceutical companies’ average annual wage was KRW 48 million
The average annual wage of employees in unlisted pharmaceutical companies, most medium and small companies, were observed to be KRW 48 million, and there were also 8 companies which paid more than KRW 70 million per e...
Concerns towards a series of multinational companies’ use patent defenses
Original pharmaceutical products have successfully defended their use patents.
The first case was Pfizer’s Lyrica(pregabalin). Validity of the drug’s use patent was accepted in handling pains by the Supreme Court, fo...
Domestic pharmaceutical companies made KRW 374 million annual sales per employee
Domestic pharmaceutical companies made KRW 374 million annual sales per employee, and Sam-O Pharm, an unlisted company, recorded the highest KRW 1.4 billion in the category.
According to the Yakup Shinmoon’s(www.yaku...
KPMA unveiled illegal rebate types; impacts are inevitable in pharmaceutical industry
The Korea Pharmaceutical Manufacturers Association(KPMA) held the 3rd board meeting on the 26th, and decided to accelerate efforts to establish ethical management after reading major types of illegal rebates mentioned...
Boehringer-Lilly-Yuhan marketing cooperation for ‘Jardiance’
When it came to the launch of ‘Jardiance,’ an SGLT-2 inhibitor antidiabetic, Boehringer Ingelheim Korea, Lilly Korea and Yuhan Corporation announced a joint marketing/sales plan.
The 3 companies held a ceremony to f...
Domestic pharmaceuticals record 57% cost/sales rate, causing on marketability
It was observed the domestic pharmaceutical companies’ cost/sales rate was 57% on average, and was approximately 10% lower than the one of multinational pharmaceutical companies branched in Korea.
It basically shows ...
